Communiqués IM Cannabis Corp. Nasdaq

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 05/06/2024			Varia. 5j.	Varia. 1 janv.
0,499 ^USD	-4,04%		-16,40%	+39,78%

08/05	Transcript : IM Cannabis Corp., Q1 2024 Earnings Call, May 08, 2024
08/05	IM Cannabis Corp. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

IMC announces the termination of a preliminary term sheet with Kadimastem Ltd., a public company traded on the Tel Aviv Stock Exchange to fully focus on the recently legalized German market	28/05	AQ
IM Cannabis : Transcript	08/05	PU
IM Cannabis : Financial Statements Q1 2024	08/05	PU
IM Cannabis : Management's Discussion and Analysis Q1 2024	08/05	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/05	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	04/04	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/03	PU
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company	28/02	AQ
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition	15/01	AQ
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	07/12	PU
IM Cannabis : REPORT OF VOTING RESULTS - Form 6-K	07/12	PU
IM Cannabis : Management's Discussion and Analysis Q3 2023	14/11	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/11	PU
IM Cannabis : NOTICE-AND-ACCESS NOTIFICATION TO BENEFICIAL SHAREHOLDERS OF IM CANNABIS CORP - Form 6-K	31/10/23	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	03/10/23	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	05/09/23	PU
IM Cannabis : Management's Discussion and Analysis Q2 2023	14/08/23	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	02/08/23	PU
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/07/23	PU
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement	13/06/23	AQ

Aucun résultat pour cette recherche